|
Anthropometric variables
|
Omega-3 (n = 30)
|
Placebo (n = 30)
|
P
|
P†
|
|---|
|
Weight, kg
| | |
0.71
|
0.61
|
|
Baseline
|
78.0 ± 10.5
|
77.1 ± 12.5
|
|
Week 12
|
78.0 ± 11.1
|
76.8 ± 13.8
|
|
Mean change
|
0.0 ± 2.3
|
− 0.3 ± 2.3
|
|
BMI, kg/m2
| | |
0.59
|
0.56
|
|
Baseline
|
30.2 ± 3.6
|
29.8 ± 4.2
|
|
Week 12
|
30.2 ± 3.7
|
29.6 ± 4.5
|
|
Mean change
|
0.0 ± 0.8
|
−0.2 ± 0.8
|
|
WC, cm
| | |
0.59
|
0.27
|
|
Baseline
|
106.7 ± 9.1
|
104.2 ± 9.8
|
|
Week 12
|
106.1 ± 8.2
|
104.8 ± 9.6
|
|
Mean change
|
−0.7 ± 3.7
|
0.6 ± 3.2
|
- P values are computed by independent t-test and data are expressed as mean ± standard deviation (SD)
- P: resulted from comparing the means of each variable at the end of the study, between two groups
- P†: resulted from comparing the mean change from baseline between groups
- NAFLD Non-alcoholic fatty liver disease, BMI Body mass index, WC Waist circumference
